Comprehensive Weight Loss Program in Atlanta, GA
The medication is the part everyone talks about and the smallest part of what actually works. A medically supervised weight-management program is the structure around it — the evaluation that decides whether treatment is appropriate at all, the monitoring that catches problems early, the protein and resistance training that protect the muscle you would otherwise lose, and the maintenance plan that exists before you need it. A prescription without that scaffolding is not a program, and the difference shows up months later.
The Benefits
Medically Supervised
Treatment is supervised by a licensed provider, with an evaluation that determines whether pharmacotherapy is appropriate at all rather than assuming it.
More Than A Prescription
The program is the structure around the medication — evaluation, monitoring, nutrition, training, and a maintenance plan — rather than a prescription with appointments attached.
Protein And Muscle
Protein intake and resistance training are treated as central, because weight lost in any deficit includes muscle and appetite suppression makes protein easy to neglect.
Monitoring Built In
Scheduled monitoring adjusts dosing and catches side effects before they become complications, which is where supervision earns its keep.
A Chronic Condition
Weight is managed as a chronic condition rather than a temporary state, which is what the physiology of weight regulation actually supports.
Titration, Not Racing
Dose escalation is slow and individualized, with holding, extending, or stepping back down treated as normal clinical responses rather than failures.
A Maintenance Plan
A maintenance plan exists before it is needed, which is the phase that determines whether the result lasts.
Some People Get A No
A responsible program declines to treat people for whom pharmacotherapy is not appropriate, including where a history suggests disordered eating.
Real Results
Before & After
After
Before
After
BeforeWhat Comprehensive Weight Loss Program Is
A comprehensive weight-management program is a structured, physician-supervised approach to weight as a medical condition. It typically combines a full clinical evaluation, laboratory assessment, prescription pharmacotherapy where appropriate, nutritional guidance, activity and resistance-training recommendations, scheduled follow-up, and a defined plan for what happens when the initial phase ends.
The framing matters. Obesity is managed medically as a chronic, relapsing condition rather than as a temporary state to be corrected and forgotten. The physiology supports that framing: when body weight falls, the body defends against the loss through hormonal and metabolic adaptations that increase appetite and reduce energy expenditure, and those adaptations persist. This is why sustained weight loss through willpower alone fails for most people, and it is not a moral fact about them. Treating weight as a chronic condition means expecting long-term management rather than a course with a finish line.
The pharmacologic component is usually an incretin-based medication — a GLP-1 receptor agonist such as semaglutide, or a dual GIP and GLP-1 receptor agonist such as tirzepatide — prescribed as an adjunct to a reduced-calorie diet and increased physical activity rather than as a replacement for either. Those medications have their own pages, and the details of how they work, who they suit, and what they carry in the way of warnings belong there.
What distinguishes a comprehensive program from a prescription is everything around the medication. A proper evaluation establishes whether pharmacotherapy is appropriate at all, screens for contraindications including thyroid cancer history, pancreatitis, gallbladder disease, and eating disorders, reviews every other medication you take, and orders laboratory work indicated by your history. Ongoing monitoring adjusts dosing, catches side effects before they become complications, and tracks the things that matter beyond the number on a scale.
The elements people underestimate are nutritional and muscular. Weight lost in any calorie deficit includes lean muscle mass, and appetite suppression makes it easy to undereat protein badly without noticing. Protecting muscle through adequate protein intake and resistance training is not a wellness flourish appended to the medical part — it is central to whether the weight you lose is the weight you wanted to lose, and to whether the result is sustainable.
A genuine program also tells some people no. If your history contains a contraindication, if what you are describing is disordered eating, or if the honest assessment is that pharmacotherapy is not appropriate for you, a responsible program says so.
How It Works
The program begins with an evaluation, and the evaluation is the part that determines whether everything after it is safe. A licensed provider takes a full medical history, reviews every medication and supplement, asks about weight history and prior attempts, and screens specifically for the conditions that contraindicate incretin-based therapy — personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, pancreatitis, gallbladder disease, severe gastrointestinal disease or gastroparesis, kidney disease, diabetic retinopathy, current or past eating disorders, and pregnancy or plans to conceive. Baseline measurements and laboratory work follow from that history rather than from a fixed panel.
Where pharmacotherapy is appropriate, treatment begins at a low introductory dose that sits deliberately below the effective range. That first dose exists to let the gastrointestinal tract adapt rather than to produce weight change. The dose is then increased stepwise at intervals set by the prescriber, and only if the current dose is being tolerated. Titration is the single most important lever for tolerability, and holding a dose, extending an interval, or stepping back down are all normal clinical responses to side effects rather than failures.
Monitoring runs alongside. Follow-up is more frequent early and around dose increases, then at longer intervals once things are stable. What is being watched includes tolerability, hydration, blood pressure, glycemic measures where relevant, and the specific warning signs that distinguish an expected side effect from a developing complication — persistent vomiting, severe abdominal pain, gallbladder symptoms, and signs of dehydration among them.
The non-pharmacologic components address what the medication does not. Appetite suppression reduces total intake, which reduces protein intake unless it is deliberately prioritized — and protein is what preserves lean muscle in a deficit. Resistance training provides the stimulus that tells the body to retain muscle rather than metabolize it. Hydration matters more than usual, because reduced appetite reduces fluid intake and dehydration is the mechanism by which this class of medication can cause acute kidney injury. None of this is optional advice appended to the medical part; in the clinical trials that established these medications, lifestyle intervention was always present.
Maintenance is planned rather than improvised. The appetite-regulating effect of incretin therapy lasts only as long as the medication is present, and published follow-up consistently shows that appetite returns and substantial regain is common after discontinuation. A program that has not discussed what happens at the end has left out the part that determines whether any of it lasts.
What Comprehensive Weight Loss Program Treats
Chronic weight management under medical supervision
The core purpose. Pharmacotherapy is used within approved labeling for adults meeting clinical criteria, assessed by a licensed provider rather than self-determined, and always alongside diet and activity change.
Repeated cycles of loss and regain
The pattern that brings most people to a program. The physiological adaptations that defend body weight after loss are the reason it happens, and treating them as a medical problem rather than a discipline problem is the point of the approach.
Appetite and food preoccupation
Persistent, intrusive hunger is a physiological signal, not a character flaw. Where pharmacotherapy is appropriate, reducing that signal is often what makes the behavioral changes people have already attempted finally sustainable.
Weight-related metabolic risk
Evaluation routinely considers high blood pressure, dyslipidemia, prediabetes, and obstructive sleep apnea. These inform whether treatment is indicated, and they are monitored alongside it rather than assumed to resolve.
Protecting lean muscle during weight loss
A central concern rather than an afterthought. Weight lost in any deficit includes muscle, appetite suppression makes protein intake easy to neglect, and losing muscle is how a good outcome becomes a poor one.
Weight maintenance after loss
The phase most programs handle worst and the one that determines the long-term result. Metabolic adaptation and returning appetite both push weight back up, and a plan for that should exist before it is needed.
Nutritional guidance alongside medication
Reduced appetite makes adequate protein, hydration, and micronutrient intake harder rather than easier. Guidance on eating well while eating less is a substantive part of a program.
Not a treatment for an eating disorder
Listed deliberately. Appetite-suppressing medication can be actively harmful in the presence of a current or past eating disorder, and a program should screen for this and refer appropriately rather than prescribe.
Is Comprehensive Weight Loss Program Right For You?
You May Be A Good Candidate If
- Adults who meet the clinical criteria for pharmacologic weight management under approved labeling — criteria involving body mass index thresholds and weight-related conditions, assessed by a licensed provider rather than self-determined.
- People who have made genuine, sustained attempts at diet and activity change and found that appetite and metabolic adaptation kept undoing them.
- People prepared to treat this as long-term medical management rather than a short course to be abandoned once a number is reached.
- People willing to commit to the non-pharmacologic side: adequate protein at every meal, resistance training, hydration, and honest reporting of side effects.
- People who can give a complete and accurate medical history, including every medication and supplement and any relevant family history.
- People willing to titrate slowly, since pushing the schedule faster than the gut tolerates is the commonest way this goes badly.
- People who want monitoring and follow-up rather than a prescription obtained with minimal assessment.
- People without any contraindication, as determined at a medical evaluation.
This May Not Be Right For You If
- Anyone with a personal or family history of medullary thyroid carcinoma, or with Multiple Endocrine Neoplasia syndrome type 2. This is an absolute contraindication carried in the boxed warning for incretin-based medications.
- Anyone who is pregnant, trying to conceive, or breastfeeding.
- Anyone with an active or recent eating disorder, or a history of one, where appetite-suppressing medication can be actively harmful. A program should screen for this and refer rather than prescribe.
- Anyone with a history of pancreatitis, which requires specialist input and is generally a reason not to prescribe this class.
- Anyone with severe gastrointestinal disease, gastroparesis, or significant delayed gastric emptying, since the mechanism directly worsens that physiology.
- Anyone with active gallbladder disease, and with caution anyone with a history of gallstones, diabetic retinopathy, significant kidney disease, or thyroid nodules — each requiring specific evaluation.
- Anyone taking insulin or a sulfonylurea without coordinated management, since the combination carries a real risk of hypoglycemia and those doses must be reviewed by the prescriber.
- Anyone with known hypersensitivity to the medication proposed or to any component of its formulation.
- Anyone under 18, for whom these medications are not established outside specific approved indications assessed by a physician.
- Anyone seeking rapid weight loss before a specific date, which is neither how these medications work nor a safe framing for treatment.
- Anyone unwilling to engage with the nutritional and training components, since medication alone produces a worse outcome and risks the muscle loss the program exists partly to prevent.
- Anyone whose weight concern is driven by body image distress rather than by health, where the right referral is not a weight program.
The evaluation is where a genuine program distinguishes itself, and it should feel thorough rather than perfunctory. Expect a full history, direct questions about thyroid cancer, pancreatitis, gallbladder disease, kidney disease, eating disorders, and pregnancy, a complete medication review, and laboratory work indicated by what you disclose. Expect an informed-consent conversation covering the boxed warning, the common and serious side effects, the fact that the medication is an adjunct to diet and activity, and the likelihood of regain if treatment stops. Ask what is being prescribed — an FDA-approved product or a compounded preparation — and what that distinction means, since it is a meaningful one and should be volunteered rather than extracted. Ask what monitoring is included, what the protein target is, and what the maintenance plan looks like. If those questions do not have ready answers, what you are being offered is a prescription rather than a program.
How Comprehensive Weight Loss Program Compares
What is on offer under the heading of medical weight loss varies enormously, and the differences are worth seeing plainly.
| Feature | Comprehensive supervised program | Prescription-only telehealth | Structured lifestyle program | Bariatric surgery |
|---|---|---|---|---|
| Initial evaluation | Full history, examination, and laboratory work as indicated | Varies widely; sometimes a questionnaire | Nutritional and behavioral assessment | Extensive multidisciplinary evaluation |
| Medication | Prescribed where appropriate, titrated and monitored | The central offering | None | Sometimes used alongside |
| Ongoing monitoring | Scheduled follow-up, dose adjustment, side-effect management | Varies; often minimal | Regular contact, behaviorally focused | Long-term surgical and nutritional follow-up |
| Muscle preservation addressed | Protein targets and resistance training as core components | Frequently not addressed | Usually addressed | Addressed, and a known long-term concern |
| Maintenance planning | Planned from the outset | Often absent | Central to the approach | Lifelong follow-up expected |
| Will decline inappropriate candidates | Yes — screening is part of the point | Depends entirely on the service | Generally low-risk for most people | Yes, with formal criteria |
| Best suited to | People wanting medication within a supervised structure | People wanting convenience and lower cost | People for whom medication is not indicated or not wanted | People meeting surgical criteria after other approaches |
| Main limitation | Requires attendance and commitment to the non-medication parts | The scaffolding that makes medication work is often absent | Appetite and metabolic adaptation remain unaddressed pharmacologically | A major operation with permanent consequences |
The column that deserves scrutiny is the second. Obtaining a prescription is easy and getting it right is not — the evaluation that screens for contraindications, the titration that determines tolerability, the monitoring that catches complications, and the protein and training that protect muscle are all things that happen around the medication. A service that supplies only the drug is supplying the least difficult part.
What To Expect
Before The Treatment
- A full medical evaluation: history, examination, weight history and prior attempts, and a complete review of every medication and supplement you take.
- Direct screening questions about thyroid cancer and MEN 2, pancreatitis, gallbladder disease, kidney disease, gastrointestinal disorders, diabetic retinopathy, eating disorders, oral contraception, and pregnancy or plans to conceive.
- Baseline measurements and any laboratory work your history indicates, which may include metabolic and kidney panels and glycemic measures. What is ordered depends on your clinical picture rather than a fixed panel.
- An informed-consent discussion covering the boxed warning regarding thyroid C-cell tumors, contraindications, common and serious side effects, the adjunct nature of the medication, and the likelihood of regain after stopping.
- A clear answer about what is being prescribed — an FDA-approved product or a compounded preparation — and what that distinction means.
- A titration plan, instruction in injection technique and storage, and guidance on what to do about a missed dose.
- A plan for the non-medication components: protein targets, resistance training, hydration, and the follow-up schedule.
- An explicit conversation about what maintenance will look like, before treatment starts rather than when it ends.
Results: Onset And How Long It Lasts
Change is gradual and unfolds over months as dosing is titrated upward and behavioral changes accumulate. Appetite effects are often noticed within the first weeks; weight change is slow by design, and a program that promises rapid results is not describing how this works. What a comprehensive approach adds beyond medication alone is the composition and durability of the outcome rather than the speed of it: adequate protein and resistance training substantially affect whether the weight lost is fat or muscle, and a planned maintenance phase substantially affects whether it stays lost. Responses vary considerably between individuals — some respond well, some modestly, and a proportion do not respond meaningfully to a given medication at all. This page publishes no numeric efficacy figures: trial averages say nothing reliable about any individual, and quoting them would misrepresent what you can expect. Ask your provider what the approved labeling and published data show for your specific situation. What should be understood before starting is that obesity is managed as a chronic condition — the appetite-regulating effect of incretin therapy lasts only as long as the medication is present, and published follow-up consistently shows appetite returns and substantial regain is common after discontinuation. That is not a failure of treatment; it is the nature of the condition, and it is why maintenance is planned from the outset rather than improvised at the end.
During The Treatment
- Regular follow-up appointments, more frequent early and around dose increases, then at longer intervals once you are stable.
- Weight, measurements, and relevant clinical parameters reviewed at each visit, alongside tolerability and side effects.
- Dose adjustment based on tolerance and response. Holding a dose, extending the interval, or stepping back down are all normal responses to side effects.
- Ongoing nutritional guidance, with particular attention to protein intake, since reduced appetite makes it easy to undereat protein without noticing.
- Review of resistance training and activity, which is what tells the body to retain muscle rather than metabolize it.
- Attention to hydration, which falls with appetite and is the pathway by which this class of medication can cause acute kidney injury.
- Review of any other medications, particularly insulin or a sulfonylurea, which may need adjusting.
- Honest conversations about what is and is not working, including whether continuing is appropriate.
How Often, And Why
Follow-up is more frequent at the start and around dose increases, then moves to longer intervals once you are stable on a maintenance dose. That cadence is set by your provider and reflects where the risk actually sits: escalation is when side effects cluster and when dose decisions matter most.
The medication itself is generally dosed weekly, beginning at a low introductory dose and increasing stepwise at intervals set by the prescriber, and only where the current dose is tolerated. Many people settle at a maintenance dose well below the maximum, which is a legitimate outcome rather than a half-measure.
The longer question is how long the program continues, and the honest answer is that it is framed as long-term management rather than a course. The appetite-regulating effect lasts only while the medication is present, and published follow-up consistently shows that appetite returns and substantial regain is common after discontinuation. Some people continue therapy specifically for maintenance rather than further loss; others taper or stop with a structured plan in place. Either way it should be a planned conversation with a maintenance strategy rather than a decision to simply stop injecting.
The non-pharmacologic components do not have an interval — they are continuous. Protein at every meal, resistance training at least twice weekly, and adequate hydration continue throughout treatment and beyond it, and they matter more during maintenance than during active loss, because they are what the result rests on once the medication is no longer doing the appetite work.
Afterward
- Continue the reduced-calorie diet and increased physical activity that the medication is prescribed as an adjunct to.
- Prioritize protein at every meal and do resistance training at least twice weekly. This is the single most important thing you can do to ensure the weight you lose is fat rather than muscle.
- Hydrate deliberately, since reduced appetite reduces fluid intake and dehydration alongside vomiting or diarrhea is how acute kidney injury happens.
- Manage nausea proactively: smaller portions, eating slowly, stopping at the first sense of fullness, avoiding large fatty meals, and not lying down immediately after eating.
- Report side effects rather than enduring them silently. Titration can be slowed or held, and that is a normal clinical response.
- Attend follow-up as scheduled, including when things are going well. Follow-up is where problems get caught early.
- If you take oral hormonal contraception, follow the guidance you were given about backup methods after starting and after each dose increase.
- Report promptly: severe or persistent abdominal pain, persistent vomiting, gallbladder symptoms, a lump or swelling in the neck, hoarseness, or trouble swallowing.
- Tell every clinician who treats you that you take an incretin-based medication, especially before surgery, endoscopy, or any procedure involving sedation.
- Engage with the maintenance plan when the time comes rather than simply stopping. Stopping without a plan is how regain happens.
How Much Does Comprehensive Weight Loss Program Cost in Atlanta, GA?
- What it is priced by: Per 2 months
- Typical cost: From $850 / 2 months
- Good to know: The site's Comprehensive Program card includes a 2-month supply, follow-ups and InBody scans.
The figure above is a starting point, not a quote. What you pay depends on how much product your anatomy actually needs, which is a clinical judgement made in person. Ask at your consultation.
Side Effects And Downtime
Common And Expected
- Nausea, most pronounced during dose escalation and often improving as the body adapts to each level
- Vomiting
- Diarrhea or constipation
- Abdominal pain, cramping, or bloating
- Acid reflux, heartburn, or indigestion
- Reduced appetite to the point of inadequate eating or drinking, which is worth watching rather than welcoming
- Fatigue
- Headache and dizziness
- Hair thinning associated with rapid weight loss generally
- Injection-site reactions such as redness, itching, or a small bump
- Loss of facial volume, which is a common and under-discussed consequence of substantial weight loss
When To Seek Care
- Severe, persistent abdominal pain, especially radiating to the back, with or without vomiting. This can be pancreatitis. Stop the medication and seek emergency care.
- Persistent vomiting or diarrhea, inability to keep fluids down, or signs of dehydration such as dark urine, markedly reduced urination, dizziness on standing, or confusion.
- Symptoms of a gallbladder attack: pain in the upper right abdomen, fever, jaundice, or clay-colored stools.
- A lump or swelling in the neck, persistent hoarseness, trouble swallowing, or shortness of breath, given the boxed warning regarding thyroid C-cell tumors.
- Signs of a serious allergic reaction: rash or hives, swelling of the face, lips, tongue, or throat, or difficulty breathing. Call 911.
- Symptoms of low blood sugar — shakiness, sweating, confusion, rapid heartbeat, blurred vision — particularly if you take insulin or a sulfonylurea.
- Any new or worsening vision change, especially if you have diabetes.
- Marked or rapid loss of strength, which may indicate excessive muscle loss and warrants review of protein intake and training.
Less Common, But Important To Know
- Boxed warning — thyroid C-cell tumors: incretin-based medications caused thyroid C-cell tumors in rodent studies, including medullary thyroid carcinoma. Whether this occurs in humans has not been determined, and these medications are contraindicated with a personal or family history of MTC or MEN 2.
- Pancreatitis — uncommon but serious, presenting as severe persistent abdominal pain that may radiate to the back. Stop the medication and seek medical care immediately.
- Gallbladder disease, including gallstones and cholecystitis, associated both with incretin therapy and with rapid weight loss generally.
- Dehydration and acute kidney injury, typically driven by persistent vomiting or diarrhea, and among the more preventable serious complications.
- Aspiration under anesthesia, since delayed gastric emptying means food may remain in the stomach longer than expected during sedation.
- Hypoglycemia, uncommon with these medications alone in people without diabetes but a genuine risk combined with insulin or sulfonylureas.
- Reduced effectiveness of oral hormonal contraception, particularly after starting and after each dose increase.
- Excessive loss of lean muscle mass, which is a real risk where protein intake and resistance training are neglected and is a poor outcome disguised as a good number.
- Nutritional deficiency from sustained low intake without guidance.
- Worsening of diabetic retinopathy in people with diabetes, increased heart rate, gastroparesis or ileus, and serious hypersensitivity reactions including angioedema.
- Psychological difficulty as weight changes, including for people with a history of disordered eating, which is a reason for screening and support rather than a rare curiosity.
Downtime
There is no procedural downtime — a weekly injection takes seconds and there is nothing to recover from. The real story is gastrointestinal and it is concentrated around dose increases. The days after an injection, and particularly the week or two following each escalation, are when nausea, reflux, constipation, or fatigue are most likely. For many people these are manageable and settle as the body adapts. For some they are significant enough that titration must be slowed, held, or reversed, and for a minority they are a reason to stop altogether. Plan dose increases for weeks with some flexibility rather than immediately before something demanding, and report what you are experiencing rather than pushing through it silently. Fatigue during active weight loss is common and worth accounting for when planning training and work.
Who Performs This Treatment
Sharon Williams, NP-C
Aesthetic Injector, Nurse Practitioner · Injectables, neuromodulators, filler and facial balancingA bilingual (English/Spanish) nurse practitioner who came to aesthetics after more than a decade in medicine, including work as an RN across two hospitals, and earned her Master's degree in 2023. She describes her medical foundation as having shaped a thoughtful, safety-focused approach to injecting, centered on facial harmony and natural-looking results.
Comprehensive Weight Loss Program FAQs
Everything around the medication. The evaluation that screens for contraindications and decides whether treatment is appropriate at all, the titration that determines whether you tolerate it, the monitoring that catches complications early, the protein and training that protect your muscle, and the maintenance plan that determines whether any of it lasts. Obtaining a prescription is the least difficult part of this.
Yes, and it is one of the most important things in the program. Weight lost in any calorie deficit includes lean muscle, and appetite suppression makes it easy to undereat protein badly without noticing. Resistance training is the signal that tells your body to retain muscle rather than metabolize it. Losing a lot of muscle is a poor outcome disguised as a good number on the scale.
Slowly, and deliberately so. The starting dose sits below the effective range and exists mainly to let your gut adapt. Meaningful change unfolds over months as the dose is titrated upward. This page does not publish numeric figures because trial averages say nothing reliable about any individual — ask your provider what the labeling and data show for your situation.
Appetite returns, because the effect lasts only while the medication is present, and published follow-up consistently shows substantial regain is common after discontinuation. This is why obesity is managed as a chronic condition and why a maintenance plan should exist before you need it. If a program has not discussed the end at the beginning, it has left out the part that determines whether it worked.
Possibly, and a program that never does is not screening properly. A personal or family history of medullary thyroid carcinoma or MEN 2 is an absolute contraindication. A history of pancreatitis, active gallbladder disease, severe gastrointestinal disease, pregnancy, or a current or past eating disorder are all reasons a responsible provider declines or refers elsewhere.
Because the same mechanism that reduces appetite also slows gastric emptying, and the gut needs time to adapt to each step. Escalating faster than tolerated is the commonest route to severe nausea, vomiting, and dropping out of treatment. Holding a dose or stepping back down when side effects bite is normal clinical practice, not a setback.
No. Compounded preparations are not FDA-approved and are not reviewed for safety, effectiveness, or quality in the way approved products are, and their availability has shifted with drug-shortage determinations over time. Ask directly what is being prescribed, where it is sourced, and what dosing units are being used. A clear answer is reasonable to expect.
Facial fat is lost along with fat everywhere else, and the temples and midface are among the more visible casualties. It is a common and under-discussed consequence of substantial weight loss. If it bothers you, it is treatable — but it is generally sensible to wait until your weight has stabilized, since further loss will change any result.
Yes. These medications are prescribed as an adjunct to a reduced-calorie diet and increased physical activity, and in the clinical trials that established them, lifestyle intervention was always present. The medication makes appetite far easier to manage. It does not make the nutritional and activity changes for you, and a program suggesting otherwise is misleading you.
That is a real outcome for a proportion of people, and an honest program will have raised it beforehand. Response varies considerably, and someone who does not respond meaningfully to one medication may respond to another, or may be better served by a different approach entirely. That is a clinical conversation rather than a reason to escalate the dose indefinitely.
You should disclose it, and expect the answer to be careful. Appetite-suppressing medication can be actively harmful in the presence of a current or past eating disorder, and a responsible program screens for this and refers appropriately rather than prescribing. That may not be the answer you want, and it is the right one.
What the initial evaluation includes and whether laboratory work is part of it. What monitoring is scheduled and with whom. Whether the medication is FDA-approved or compounded. What the protein target is and whether training guidance is included. And what the maintenance plan looks like. If those questions do not have ready answers, you are being offered a prescription rather than a program.
Pairs Well With
Book Your Consultation
A consultation is a conversation about your face, not a sales appointment. Bring your questions about Comprehensive Weight Loss Program and your medical history, and leave with an honest answer about whether it is the right treatment for you.
